Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 50018475
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196192(1-[4-bromo-2-[(quinolin-5-ylsulfonyl)amino]-benzoy...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196209(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196208(N-(5-bromo-2-(piperidine-1-carbonyl)phenyl)benzo[c...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196205(2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4-ch...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196195(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196204(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196194(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)methylam...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196204(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196149(4-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]be...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196203(1-[2-[(1H-indol-2-ylsulfonyl)amino]benzoyl]-piperi...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196191(N-(5-iodo-2-(morpholine-4-carbonyl)phenyl)quinoxal...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196210(1-[4-bromo-2-[(5-quinoxalinylsulfonyl)amino]benzoy...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196164(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-3...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196199(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]na...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196198(cis-1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amin...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196197(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196196(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196194(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)methylam...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196193(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196182(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196189(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196183(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196219((R)-4-[4-chloro-2-[(5-quinoxalinylsulfonyl)amino]b...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196172(1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196153(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196218(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196217(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196220(1-[4-bromo-2-[5-methyl(2,1,3-benzothiadiazol-4-yls...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196214((3R,5S)-rel-4-[4-chloro-2-[(5-quinoxalinylsulfonyl...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196215(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196161(1-[4-acetylamino-2-[(2,1,3-benzothiadiazol-4-ylsul...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196152(N-(5-chloro-2-(piperidine-1-carbonyl)phenyl)quinol...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196211(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-6...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196182(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196206(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196213(1-[4-bromo-2-[5-fluoro(2,1,3-benzothiadiazol-4-yls...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196207(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196212(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196216(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-b...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196185(1-[2-[(2,1,3-benzothiadiazol-4-ylcarbonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196202(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196184(1-[3-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196201(1-[2-[7-bromo(2,1,3-benzothiadiazol-4-ylsulfonyl)a...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196200(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196158(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196173((S)-1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amin...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196165(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196166(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-3...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196164(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-3...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196155(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: